5AM Venture Management
Latest statistics and disclosures from 5AM Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ERAS, TRDA, TYRA, CAMP, CNTA, and represent 54.41% of 5AM Venture Management's stock portfolio.
- Added to shares of these 2 stocks: ALXO (+$6.1M), RLYB.
- Started 2 new stock positions in ALXO, RLYB.
- Reduced shares in these 4 stocks: ERAS (-$31M), VRDN (-$23M), ELVN (-$12M), Rallybio Corp.
- Sold out of its positions in ELVN, Rallybio Corp, VRDN.
- 5AM Venture Management was a net seller of stock by $-60M.
- 5AM Venture Management has $360M in assets under management (AUM), dropping by 13.24%.
- Central Index Key (CIK): 0001799883
Tip: Access up to 7 years of quarterly data
Positions held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 20 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Erasca (ERAS) | 15.7 | $56M | -35% | 3.5M | 16.18 |
|
| Entrada Therapeutics (TRDA) | 14.2 | $51M | 4.1M | 12.62 |
|
|
| Tyra Biosciences (TYRA) | 10.9 | $39M | 1.0M | 38.30 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 7.2 | $26M | 5.9M | 4.41 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 6.4 | $23M | 581k | 39.72 |
|
|
| Pharvaris N V (PHVS) | 6.3 | $23M | 798k | 28.25 |
|
|
| Maplight Therapeutics (MPLT) | 5.4 | $19M | 950k | 20.33 |
|
|
| Tectonic Therapeutic (TECX) | 5.2 | $19M | 607k | 30.91 |
|
|
| Celldex Therapeutics Com New (CLDX) | 4.4 | $16M | 497k | 31.72 |
|
|
| Artiva Biotherapeutics (ARTV) | 4.2 | $15M | 2.4M | 6.44 |
|
|
| Eyepoint Com New (EYPT) | 3.8 | $14M | 1.1M | 12.89 |
|
|
| Surrozen Com New (SRZN) | 3.1 | $11M | 388k | 29.13 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 2.6 | $9.2M | 3.9M | 2.34 |
|
|
| Gh Research Ordinary Shares (GHRS) | 2.2 | $8.1M | 573k | 14.06 |
|
|
| Protara Therapeutics Com Stk (TARA) | 2.0 | $7.1M | 1.4M | 5.21 |
|
|
| Biohaven (BHVN) | 1.7 | $6.3M | 739k | 8.46 |
|
|
| Alx Oncology Hldgs (ALXO) | 1.7 | $6.1M | NEW | 3.1M | 2.00 |
|
| Skye Bioscience Com New (SKYE) | 1.7 | $6.0M | 9.7M | 0.61 |
|
|
| Rallybio Corp (RLYB) | 0.7 | $2.6M | NEW | 292k | 8.97 |
|
| Silence Therapeutics Ads (SLN) | 0.7 | $2.5M | 476k | 5.27 |
|
Past Filings by 5AM Venture Management
SEC 13F filings are viewable for 5AM Venture Management going back to 2019
- 5AM Venture Management 2026 Q1 filed May 15, 2026
- 5AM Venture Management 2025 Q4 filed Feb. 17, 2026
- 5AM Venture Management 2025 Q3 filed Nov. 14, 2025
- 5AM Venture Management 2025 Q2 filed Aug. 14, 2025
- 5AM Venture Management 2025 Q1 filed May 15, 2025
- 5AM Venture Management 2024 Q4 filed Feb. 14, 2025
- 5AM Venture Management 2024 Q3 filed Nov. 14, 2024
- 5AM Venture Management 2024 Q2 filed Aug. 14, 2024
- 5AM Venture Management 2024 Q1 filed May 15, 2024
- 5AM Venture Management 2023 Q4 filed Feb. 14, 2024
- 5AM Venture Management 2023 Q3 filed Nov. 14, 2023
- 5AM Venture Management 2023 Q2 filed Aug. 14, 2023
- 5AM Venture Management 2023 Q1 filed May 15, 2023
- 5AM Venture Management 2022 Q4 filed Feb. 14, 2023
- 5AM Venture Management 2022 Q3 filed Nov. 14, 2022
- 5AM Venture Management 2022 Q2 filed Aug. 15, 2022